OA12440A - Histamine receptor antagonists. - Google Patents

Histamine receptor antagonists. Download PDF

Info

Publication number
OA12440A
OA12440A OA1200300174A OA1200300174A OA12440A OA 12440 A OA12440 A OA 12440A OA 1200300174 A OA1200300174 A OA 1200300174A OA 1200300174 A OA1200300174 A OA 1200300174A OA 12440 A OA12440 A OA 12440A
Authority
OA
OAPI
Prior art keywords
histamine
receptor
antagonist
sélective
fold
Prior art date
Application number
OA1200300174A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA12440A publication Critical patent/OA12440A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA1200300174A 2001-01-17 2002-01-10 Histamine receptor antagonists. OA12440A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
OA12440A true OA12440A (en) 2006-05-22

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300174A OA12440A (en) 2001-01-17 2002-01-10 Histamine receptor antagonists.

Country Status (31)

Country Link
EP (1) EP1353657A1 (fr)
JP (1) JP2004517883A (fr)
KR (1) KR20030069216A (fr)
CN (1) CN1486178A (fr)
AP (1) AP2002002401A0 (fr)
AR (1) AR032101A1 (fr)
BG (1) BG107834A (fr)
BR (1) BR0206502A (fr)
CA (1) CA2435121A1 (fr)
CR (1) CR6983A (fr)
CZ (1) CZ20031853A3 (fr)
DO (1) DOP2002000325A (fr)
EA (1) EA200300537A1 (fr)
EC (1) ECSP034692A (fr)
EE (1) EE200300335A (fr)
GB (1) GB0101223D0 (fr)
GT (1) GT200200003A (fr)
HU (1) HUP0302767A2 (fr)
IL (1) IL156087A0 (fr)
IS (1) IS6818A (fr)
MA (1) MA26980A1 (fr)
MX (1) MXPA03006408A (fr)
NO (1) NO20033223D0 (fr)
OA (1) OA12440A (fr)
PA (1) PA8537101A1 (fr)
PL (1) PL362793A1 (fr)
SK (1) SK8572003A3 (fr)
SV (1) SV2003000849A (fr)
TN (1) TNSN02003A1 (fr)
WO (1) WO2002056871A2 (fr)
ZA (1) ZA200304180B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
MXPA05002577A (es) * 2002-09-06 2005-09-20 Johnson & Johnson Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma.
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (fr) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére

Also Published As

Publication number Publication date
JP2004517883A (ja) 2004-06-17
BR0206502A (pt) 2003-10-21
TNSN02003A1 (fr) 2005-12-23
HUP0302767A2 (hu) 2003-11-28
ECSP034692A (es) 2003-08-29
CR6983A (es) 2003-11-25
GB0101223D0 (en) 2001-02-28
EP1353657A1 (fr) 2003-10-22
MXPA03006408A (es) 2003-10-15
CZ20031853A3 (cs) 2004-07-14
KR20030069216A (ko) 2003-08-25
IS6818A (is) 2003-05-15
ZA200304180B (en) 2004-06-15
WO2002056871A2 (fr) 2002-07-25
BG107834A (bg) 2004-01-30
SK8572003A3 (en) 2004-07-07
PL362793A1 (en) 2004-11-02
IL156087A0 (en) 2003-12-23
AR032101A1 (es) 2003-10-22
EE200300335A (et) 2003-12-15
PA8537101A1 (es) 2002-08-29
SV2003000849A (es) 2003-01-13
MA26980A1 (fr) 2004-12-20
CN1486178A (zh) 2004-03-31
EA200300537A1 (ru) 2004-02-26
NO20033223L (no) 2003-07-16
DOP2002000325A (es) 2003-01-31
GT200200003A (es) 2002-08-19
CA2435121A1 (fr) 2002-07-25
AP2002002401A0 (en) 2002-03-31
NO20033223D0 (no) 2003-07-16

Similar Documents

Publication Publication Date Title
JP4850880B2 (ja) 疼痛の処置のためのエピナスチンの使用
US20020052312A1 (en) Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
NO337128B1 (no) Anvendelse av en kombinasjon av R,R-glykopyrrolat og et langtidsvirkende β2-mimetisk middel for fremstilling av et medikament for behandling av respiratoriske sykdommer og fremgangsmåte for fremstilling av et farmasøytikum
HUT74949A (en) Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
KR20060017570A (ko) 무호흡증, 대식증, 다른 질환을 치료하기 위한 광학적으로순수한 (+)-노르씨사프라이드의 용도
WO2008002514A2 (fr) Combinaison de composés pour le traitement de la toux et procédé de traitement des toux courantes
JP2003176240A (ja) ニコチン性アセチルコリン受容体作用薬により関節の潤滑を高める方法
AU2008259864B2 (en) Methods and compositions for administration of Oxybutynin
JP2655706B2 (ja) 抗パーキンソン病エルゴリン誘導体
JP2001515475A (ja) 尿失禁、動揺病及びめまいの治療薬の製造のためのデスカルボエトキシロラタジンの使用
WO2004067006A1 (fr) Combinaison d'un inhibiteur de la pde iv et d'un antagoniste du tnf-alpha
JP2000198734A (ja) 胃運動性減弱および関連疾患の治療のための運動性増強薬
OA12440A (en) Histamine receptor antagonists.
US20020132755A1 (en) Histamine receptor antagonists
JP2001526217A (ja) 血管性頭痛に対する局所麻酔薬の新規な使用
AU2008333220B2 (en) Mequitazine for treating or preventing pathologies involving histamine H4 receptors
AU2002216328A1 (en) Histamine receptor antagonists
Chung et al. New Drugs: Respiratory and allergic disease—I
WO2014061827A1 (fr) Traitement de la fibrose pulmonaire à l'aide d'un inhibiteur de la cbp/caténine
RU2356555C2 (ru) Антинейтрофильное средство
Fassoulaki et al. Flumazenil reduces the duration of thiopentone but not of propofol anaesthesia in humans
EP4210701A1 (fr) Composé destiné à être utilisé dans le traitement de la sécheresse buccale
JPH1160483A (ja) Tnf産生阻害剤
EP1435238A1 (fr) Méthode de traitement de l'apnée et des troubles de l'apnée à l'aide de l'R(+)ondansétron optiquement pur
MX2007014396A (es) Composicion farmaceutica que comprende 1-(3-clorofenil)-3- alquilpiperazina para el tratamiento de trastorno alimenticio.